Event Posts

Real-World AI in Pharma Writing: AuroraPrime Showcased at EMWA 2025

At the heart of this year’s EMWA Spring Conference in Riga was a shared commitment to advancing medical writing through innovation—and AlphaLife Sciences was proud to be part of the momentum. From dynamic conversations at Booth 1 to a standout session by our Head of AI Product & Strategy, Mike Liang, the spotlight was on how GenAI is reshaping regulatory writing for global pharma. With real-world demos, proven results, and a closer look at our AuroraPrime platform, it was clear: the future of clinical document authoring is already here.

Shaping the Future of Regulatory Submissions: A Recap of Sharon Chen's Insights at the DIA RSIDM Forum

We are thrilled to share our insight from the DIA RSIDM Forum! 🚀

AlphaLife Sciences Engages with Global Industry Leaders at Biotech Showcase 2025 in San Francisco

AlphaLife Sciences actively participated in the Biotech Showcase 2025, held from January 13 to 15 in San Francisco. CEO Sharon Chen joined the panel discussion titled "Singapore: Launchpad for Life Science Innovation in Asia Pacific," moderated by Sharon Chan, VP of JLABS Asia Pacific. The panel also featured industry leaders such as Huren Sivaraj, Co-Founder and CEO of Oncoshot. The event facilitated discussions on Singapore's role as a regional innovation hub and fostered potential collaborations to strengthen the life sciences ecosystem in the Asia Pacific.

Revolutionizing Clinical Research at APAC MedTech Forum 2024!

AlphaLife Sciences expands its presence by joining BIO HK 2024, showcasing GenAI-powered solutions for clinical research at this leading biotech event.

Event: Alphalife Sciences Highlights GenAI-Driven Automation in Clinical Trials at 2024 SAPA-DC Annual Conference

At the 2024 SAPA-DC Annual Conference, AlphaLife Sciences CEO Sharon Chen highlighted AuroraPrime, a GenAI-powered platform that automates clinical trial processes. Tools like AuroraPrime Create and AuroraPrime Comprehend streamline document drafting and data monitoring, driving innovation in clinical research through GenAI and strategic partnerships.

Transforming Clinical Trials with AI: AlphaLife Sciences at B Capital’s 2024 Annual Event

Driving the Future of Clinical Trials: AI Solutions for Clinical Research at SCDM 2024

AlphaLife Sciences Leads the Way at BioTechX 2024 and DPharm 2024: Revolutionizing Medical Writing with AI

AlphaLife Sciences at BIOHK 2024: Pioneering AI-Powered Medical Writing for Clinical Trials and FDA Submissions

Revolutionizing Clinical Trials with AI: Presenting at 'Artificial Intelligence in Drug Development' Event

AlphaLife Sciences Invited to Attend the AI in Pharma Annual Conference | October 4-5 in Boston

The 2023 AI in Pharma Conference, on October 4-5 in Boston, focuses on AI applications and challenges in drug discovery and clinical trials.

AlphaLife Sciences Invited to Attend SAPA Annual Meeting | September 29-30 in New Jersey

Join the 2023 SAPA Annual Meeting on September 29-30 in New Jersey, sponsored by AlphaPrime Life Sciences, to explore innovation in pharmaceuticals.